On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...
CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...
Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.
FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...
Learn how radiopharmaceuticals are transforming cancer treatment and creating new opportunities for biotech and pharma ...
Hosted on MSN
Scientists reveal new cancer-fighting nanobots
Recent advancements in nanotechnology have paved the way for innovative approaches in the fight against cancer. Scientists have unveiled groundbreaking cancer-fighting nanobots, promising a revolution ...
Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its ...
Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Stream Los Angeles News for free, 24/7, wherever you are. Drugmakers have poured billions of dollars into ...
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.
Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...
Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results